Royalmount Biopharma Services

About Royalmount Biopharma Services

Royalmount Biopharma Services, a division of Pharmascience, featuring two business units: CDMO Services & Lab Services. Our Lab division delivers high-precision bioanalytical services for preclinical and clinical studies using advanced platforms. CDMO Services, at our FDA-approved facility, provides end-to-end development for small & large molecules, including cytotoxic products, with exclusive partnerships enabling preclinical and clinical trials. RBS combines scientific excellence, regulatory expertise, & operational agility to support biopharmaceutical partners.

Certifications
  • Country/Region:
    Canada
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Contract Manufacturer
Contract Research Organisation
Laboratory Services
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Royalmount Biopharma Services (2)

  • Analytical Laboratory Services

    Product Analytical Laboratory Services

    Royalmount Laboratories boast a purpose-built, partially automated, state-of-the-art GLP certified and FDA inspected laboratory. This laboratory provides robust bioanalytical method development and validation for quantification of drugs and metabolites in biological fluids/tissues using LC/MS/MS technology...
  • Contract Development Manufacturing Services

    Product Contract Development Manufacturing Services

    Our expert R&D and manufacturing team delivers FDA & EMA approved turnkey solutions delivering CDMO and CMO competitive advantages for sterile cytotoxic injectables and solid dosage forms.